D-0729-2016 Class II Terminated
FDA drug recall D-0729-2016 was initiated by Genzyme Corporation on Feb 16, 2016 and is designated Class II. Reason for recall: Presence of Particulate Matter: Glass particles found in the product after reconstitution. The recall status is terminated (terminated Mar 2, 2017). Affected quantity: 27,022 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 9, 2016
- Initiation Date
- Feb 16, 2016
- Termination Date
- Mar 2, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 27,022 vials
Product description
Thyrogen (thyrotropin alfa for injection), 0.9 mg/mL after reconstitution, For intramuscular injection only, Rx Only, Four vials per Carton, Carton contains 2 vials of Thyrogen and 2 vials of diluent, Storage: store at 2-8 C, Genzyme Corporation, Cambridge, MA 02142, NDC 58468-1849-04.
Reason for recall
Presence of Particulate Matter: Glass particles found in the product after reconstitution.
Distribution pattern
Nationwide, Puerto Rico and Malaysia, Taiwan, Brazil, and Israel.
Code information
Lot #: E4029Y02 (carton), E4029 (vial) Exp 09/2016
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0729-2016
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Genzyme Corporation? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.